Warning: This security is no longer trading.
Astellas completes acquisition of Audentes Therapeutics
Audentes Therapeutics, Inc. (BOLD): Price and Financial Metrics
Today's Latest Price: $59.97 USD
Jan 14 7:41pm Add BOLD to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
BOLD Price/Volume Stats
Audentes Therapeutics, Inc. (BOLD) Company Bio
Audentes Therapeutics, Inc., a biotechnology company, focuses on developing and commercializing gene therapy products for patients suffering from diseases caused by single gene defects in the United States. The company was founded in 2012 and is based in San Francisco, California.
BOLD Latest News Stream
All News Types
Barron's Commentary Debt Offering Downgrade Earnings IPOs New Coverage (Bearish) New Coverage (Bullish) New Coverage (Neutral) Product News PT Lowered PT Raised PT Set (Bullish) PT Set (Neutral) Rating Reiterated (Bullish) Stock Offering Upgrade
Loading, please wait...
BOLD Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.7513 seconds.